Literature DB >> 8006308

Analysis of cellular and biochemical constituents of induced sputum after allergen challenge: a method for studying allergic airway inflammation.

J V Fahy1, J Liu, H Wong, H A Boushey.   

Abstract

To determine whether analysis of the constituents of induced sputum permits detection of changes provoked by aerosolized antigen challenge, we performed sputum induction (20-minute inhalation of aerosolized 3% saline solution) before and after aerosolized allergen challenge in eight subjects with asthma. Total cell counts and cell differentials of nonsquamous cells in induced sputum samples were determined after the samples were homogenized in dithiothreitol. Centrifugation of the entire homogenized sputum sample yielded supernatant that could be analyzed for biochemical constituents. We found that the median percentage of eosinophils and neutrophils in induced sputum samples was significantly higher 4 hours after allergen challenge neutrophils in induced sputum samples was significantly higher 4 hours after allergen challenge than at baseline (12% vs 0.5%, p < 0.05; 30.5% vs 7.5%, p < 0.05) and remained high 24 hours after challenge. Median levels of eosinophil cationic protein and histamine in induced sputum supernatants were significantly higher 4 hours after challenge than at baseline (151.3 vs 39.8 ng/ml, p < 0.05; 19.4 vs 8.8 micrograms, p < 0.05) and remained significantly higher 24 hours after challenge. Tryptase was detectable in sputum from seven of the subjects, and in these subjects, we found a trend toward an increase in median tryptase levels 4 hours after allergen challenge (4.4 vs 2.2 U/L, p = 0.09). We conclude that analysis of induced sputum after aerosolized allergen challenge reveals changes in inflammatory cells and markers similar to those reported in bronchoalveolar lavage fluid and that sputum induction is a useful noninvasive method for studying allergic airway inflammation in asthma.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8006308     DOI: 10.1016/s0091-6749(94)70052-4

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  15 in total

1.  Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults.

Authors:  M Diane Lougheed; Catherine Lemiere; Francine M Ducharme; Chris Licskai; Sharon D Dell; Brian H Rowe; Mark Fitzgerald; Richard Leigh; Wade Watson; Louis-Philippe Boulet
Journal:  Can Respir J       Date:  2012 Mar-Apr       Impact factor: 2.409

2.  Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma.

Authors:  Stephen C Lazarus; Vernon M Chinchilli; Nancy J Rollings; Homer A Boushey; Reuben Cherniack; Timothy J Craig; Aaron Deykin; Emily DiMango; James E Fish; Jean G Ford; Elliot Israel; James Kiley; Monica Kraft; Robert F Lemanske; Frank T Leone; Richard J Martin; Gene R Pesola; Stephen P Peters; Christine A Sorkness; Stanley J Szefler; Michael E Wechsler; John V Fahy
Journal:  Am J Respir Crit Care Med       Date:  2007-01-04       Impact factor: 21.405

Review 3.  Measurement of airway hyperresponsiveness: new considerations.

Authors:  J Lötvall; M Inman; P O'Byrne
Journal:  Thorax       Date:  1998-05       Impact factor: 9.139

Review 4.  The use of induced sputum to investigate airway inflammation.

Authors:  I D Pavord; M M Pizzichini; E Pizzichini; F E Hargreave
Journal:  Thorax       Date:  1997-06       Impact factor: 9.139

Review 5.  Asthma outcomes: biomarkers.

Authors:  Stanley J Szefler; Sally Wenzel; Robert Brown; Serpil C Erzurum; John V Fahy; Robert G Hamilton; John F Hunt; Hirohito Kita; Andrew H Liu; Reynold A Panettieri; Robert P Schleimer; Michael Minnicozzi
Journal:  J Allergy Clin Immunol       Date:  2012-03       Impact factor: 10.793

6.  Mometasone or Tiotropium in Mild Asthma with a Low Sputum Eosinophil Level.

Authors:  Stephen C Lazarus; Jerry A Krishnan; Tonya S King; Jason E Lang; Kathryn V Blake; Ronina Covar; Njira Lugogo; Sally Wenzel; Vernon M Chinchilli; David T Mauger; Anne-Marie Dyer; Homer A Boushey; John V Fahy; Prescott G Woodruff; Leonard B Bacharier; Michael D Cabana; Juan C Cardet; Mario Castro; James Chmiel; Loren Denlinger; Emily DiMango; Anne M Fitzpatrick; Deborah Gentile; Annette Hastie; Fernando Holguin; Elliot Israel; Daniel Jackson; Monica Kraft; Craig LaForce; Robert F Lemanske; Fernando D Martinez; Wendy Moore; Wayne J Morgan; James N Moy; Ross Myers; Stephen P Peters; Wanda Phipatanakul; Jacqueline A Pongracic; Loretta Que; Kristie Ross; Lewis Smith; Stanley J Szefler; Michael E Wechsler; Christine A Sorkness
Journal:  N Engl J Med       Date:  2019-05-19       Impact factor: 91.245

7.  Sputum induction as a research tool for sampling the airways of subjects with cystic fibrosis.

Authors:  N R Henig; M R Tonelli; M V Pier; J L Burns; M L Aitken
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

8.  Silencing IL-23 expression by a small hairpin RNA protects against asthma in mice.

Authors:  Yanchun Li; Meng Sun; Huanji Cheng; Shanyu Li; Li Liu; Hongmei Qiao; Shucheng Hua; Jirong Lu
Journal:  Exp Mol Med       Date:  2011-04-30       Impact factor: 8.718

9.  Inflammatory basis of exercise-induced bronchoconstriction.

Authors:  Teal S Hallstrand; Mark W Moody; Mark M Wurfel; Lawrence B Schwartz; William R Henderson; Moira L Aitken
Journal:  Am J Respir Crit Care Med       Date:  2005-06-09       Impact factor: 21.405

10.  Myeloperoxidase-dependent oxidative metabolism of nitric oxide in the cystic fibrosis airway.

Authors:  Anna L P Chapman; Brian M Morrissey; Vihas T Vasu; Maya M Juarez; Jessica S Houghton; Chin-Shang Li; Carroll E Cross; Jason P Eiserich
Journal:  J Cyst Fibros       Date:  2010-01-15       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.